×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SMS PHARMACEUTICALS LTD. | 1966.4 | 182.07 | 1960.47 | 2.05 | 2,154 | 29.5 |
| DR.AGARWALS EYE HOSPITAL LTD. | NA | NA | NA | NA | 2128 | 36.8 |
| Windlas Biotech Limited | 2153.29 | 176.64 | 2100.9 | 8.34 | 2123 | 32.6 |
SMS Pharmaceuticals Ltd, with Security Code 532815, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 149.4 | 135.3 | 166.6 | 161.5 | 245.8 | 164.5 | 196.7 | 173.4 | 248.2 | 196.0 |
| Expenses | 126.2 | 108.7 | 138.8 | 132.6 | 212.3 | 131.0 | 164.9 | 140.1 | 206.8 | 157.2 |
| Operating Profit | 23.2 | 26.7 | 27.8 | 28.9 | 33.5 | 33.5 | 31.9 | 33.3 | 41.4 | 38.9 |
| OPM % | 15.56% | 19.7% | 16.7% | 17.88% | 13.62% | 20.35% | 16.19% | 19.21% | 16.68% | 19.82% |
| Other Income | 1.3 | 0.5 | 0.8 | 1.5 | 1.6 | 1.4 | 1.3 | 2.1 | 1.4 | 0.6 |
| Interest | 5.9 | 6.3 | 5.6 | 6.0 | 5.6 | 4.7 | 4.6 | 4.2 | 5.1 | 5.8 |
| Depreciation | 8.0 | 7.7 | 7.9 | 8.0 | 7.9 | 8.4 | 8.6 | 8.7 | 8.6 | 9.8 |
| Profit before tax | 10.6 | 13.2 | 15.2 | 16.4 | 21.6 | 21.8 | 19.9 | 22.5 | 29.1 | 23.9 |
| Tax % | -24.1% | -29.4% | -20.5% | -25.8% | -26.3% | -25% | -28.5% | -23.8% | -28.9% | 23.7% |
| Net Profit | 8.1 | 9.3 | 12.0 | 12.2 | 15.9 | 16.3 | 14.3 | 17.2 | 20.6 | 18.2 |
| EPS in Rs | 0.95 | 1.1 | 1.42 | 1.44 | 1.88 | 1.93 | 1.68 | 2.03 | 0 | 2.05 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 148.8 | 149.4 | 135.3 | 166.6 | 161.5 | 245.8 | 164.5 | 196.7 | 173.4 | 248.2 |
| Expenses | 131.8 | 128.0 | 109.2 | 139.1 | 133.3 | 212.2 | 130.9 | 165.3 | 140.1 | 207.3 |
| Operating Profit | 17.0 | 21.4 | 26.2 | 27.5 | 28.2 | 33.6 | 33.5 | 31.5 | 33.2 | 40.9 |
| OPM % | 11.43% | 14.31% | 19.35% | 16.5% | 17.45% | 13.68% | 20.38% | 15.99% | 19.16% | 16.48% |
| Other Income | 2.2 | 1.3 | 0.5 | 0.8 | 1.5 | 1.6 | 1.4 | 1.3 | 2.1 | 1.4 |
| Interest | 5.9 | 5.9 | 6.3 | 5.6 | 6.0 | 5.6 | 4.7 | 4.6 | 4.2 | 5.1 |
| Depreciation | 8.1 | 8.0 | 7.7 | 7.9 | 8.0 | 7.9 | 8.4 | 8.6 | 8.7 | 8.6 |
| Profit before tax | 5.2 | 8.8 | 12.7 | 14.8 | 15.7 | 21.7 | 21.8 | 19.5 | 22.4 | 28.6 |
| Tax % | -20.9% | -24.1% | -30.5% | -20.5% | -25.6% | -26.2% | -25% | -29.1% | -23.9% | -29.4% |
| Net Profit | 3.8 | 6.2 | 9.3 | 11.7 | 11.5 | 17.3 | 16.5 | 14.1 | 18.2 | 20.3 |
| EPS in Rs | 0.44 | 0.73 | 1.1 | 1.39 | 1.36 | 2.04 | 1.95 | 1.69 | 2.15 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 53% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 47% |
| 3 Years: | 44% |
| 1 Year: | 30% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 47% |
| 3 Years: | 44% |
| 1 Year: | 30% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|